Full dose of Zydus Cadila's Covid vaccine at Rs 1,128

Zycov-D is the first DNA Plasmid vaccine

Zydus Cadila has received an order to supply one crore doses of ZyCoV-D, the world’s first Plasmid DNA Vaccine, to the Government of India at Rs 265 per dose and the needle-free applicator being offered at Rs 93 per dose, excluding GST.

The complete dose of Zydus Cadila's Covid vaccine will cost Rs 1,128, which is double of Covaxin and Covishield.

The pricing has been decided in consultation with the Government of India.

Speaking on the development, the Managing Director of the company, Dr Sharvil Patel said, “We are happy to support the Government’s vaccination programme with ZyCoV-D. The needle-free application of the vaccination, we hope, will motivate many more to vaccinate and safeguard themselves from Covid-19, especially children and young adults in the age group of 12 to 18 years.”

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus. It is also the first Covid-19 vaccine that is needle-free and administered using The PharmaJet a needle-free applicator to ensure painless intradermal vaccine delivery which also leads to a significant reduction in any kind of
major side effects.

ZyCoV-D has shown good stability at temperatures of around 25 degrees for at least three months. The thermostability of the vaccine will help in easy transportation and storage of the vaccine without any problems of fluctuations in temperature. For prolonged use, a temperature of 2-8 degrees is sufficient. Also being a DNA plasmid vaccine, ZyCoV-D doesn’t have any problem associated with vector-based immunity. The DNA Plasmid platform allows generating new constructs quickly to deal with mutations in the virus.

The price of the vaccine will be Rs 265 per dose. The needle-free applicator will be costing Rs 93 per dose. GST will further be added here.

Tags : #ZydusCadila #DNAPlasmidVaccine #ZycovD #CovidVaccine

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

If some countries in Asia Pacific can be on track to end AIDS then why cannot all?July 26, 2024
Karan Johar and Guneet Monga Kapoor’s 'Gyaarah Gyaarah' trailer breaks time barriers on ZEE5July 26, 2024
If some countries in Asia Pacific can be on track to end AIDS then why cannot all?July 26, 2024
Investing in India’s Path to a Healthier and Brighter FutureJuly 26, 2024
Your Medication Could Be Useless This Summer: How Heat Waves Affect Drug SafetyJuly 26, 2024
Innovative Approach to Adolescent Weight Loss: Combining Meal-Replacement Therapy with Financial IncentivesJuly 26, 2024
Promoting School Cardiopulmonary Resuscitation (CPR) Program in India: A Step Towards Saving LivesJuly 26, 2024
Education Budget 2024: A Step Towards Better Learning : Gargi Limaye July 25, 2024
AI assistant shows great promise in cataract care pathwayJuly 25, 2024
Publishing Powerhouse Devangini : A Force of Resilience and Empowerment in LiteratureJuly 25, 2024
Alarm rings in Asia Pacific for not making U-equals-U and HIV prevention accessible to allJuly 25, 2024
Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular DiseasesJuly 24, 2024
Nurturing Souls revolutionises 1000 Child-Parent Relationships for Better Career Choices & improved Mental HealthJuly 24, 2024
How to Improve Sleep Quality in Adolescents: Insights from a New StudyJuly 24, 2024
Tragic Nipah Virus Death of 14-Year-Old in Kerala: What You Need to KnowJuly 24, 2024
India Inaugurates First Overseas Jan Aushadi Kendra in MauritiusJuly 24, 2024
Budget Reaction Quote - Ms. Deepshikha Sharma, CEO, Sharp Sight Eye HospitalsJuly 23, 2024
Quote to be attributed to Mr. Jatinder Paul Singh, CEO & Co - Founder of Viacation Tourism:July 23, 2024
Budget Reaction by Anjan Bose, Founding Secretary General, NATHEALTH July 23, 2024
Mr. Niranjan Kirloskar, Managing Director, Fleetguard Filters Private Limited- BUDGET REACTIONJuly 23, 2024